Procollagen - Genetics
Research News and Information

Monday, November 23, 2009

Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts.

30 Jul 2009 OBJECTIVES: We have previously demonstrated the therapeutic potential of hepatocyte growth factor (HGF) in the treatment of vocal fold scarring, although how exogenous HGF affects gene expression of endogenous HGF or extracellular matrix components ... Read more...

Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds.

30 Jul 2009 OBJECTIVES: We investigated acute changes in extracellular matrix (ECM) gene expression and histologic changes in the deposition of collagen and hyaluronan (hyaluronic acid; HA) after basic fibroblast growth factor (bFGF) treatment of the aged rat ... Read more...

Fibronectin binds and enhances the activity of bone morphogenetic protein 1.

16 Jul 2009 Bone morphogenetic protein-1-like proteinases play key roles in formation of the extracellular matrix (ECM) in vertebrates via biosynthetic processing of precursors into mature functional proteins involved in ECM assembly. Such processing includes ... Read more...

Latest indexed articles for 'Procollagen - Genetics'

These are the very latest articles for this heading:

• Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts. 30 Jul 2009
• Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds. 30 Jul 2009
• Fibronectin binds and enhances the activity of bone morphogenetic protein 1. 16 Jul 2009
• Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. 15 Jun 2009
• Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. May 2009
• Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. 2 Mar 2009
• Extracellular matrix gene expression during wound healing of the injured rat vocal fold. 24 Feb 2009
• Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. 22 Jan 2009
• Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. 30 Dec 2008
• Perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure sensitizes offspring to angiotensin II-induced hypertension. 30 Jul 2008
• [Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: potential use of bone morphogenetic protein-2 for cartilage cell therapy] 4 Jun 2008
• Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. 4 Jun 2008
• [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model] 30 May 2008
• Potential protective effect of fresh grown unicellular green algae component (resilient factor) against PMA- and UVB-induced MMP1 expression in skin fibroblasts. 11 May 2008
• Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells. 8 May 2008
• Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis. 19 Apr 2008
• Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. 12 Mar 2008
• High dietary fat exacerbates arsenic-induced liver fibrosis in mice. 28 Feb 2008
• COL1A2 gene polymorphisms (Pvu II and Rsa I), serum calciotropic hormone levels, and dental fluorosis. 16 Feb 2008
• Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH. 8 Dec 2007

See a longer list of these articles.

Technical information about 'Procollagen'

Definition: A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.

Registry Number: 0

Descriptor UI: D011347

Alternative terms: Procollagen; Procollagen Type M; Protocollagen;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D12.776.811.690; D12.776.860.300.250.600;

History Note: 77

Technical Notes: coord IM with specific collagen (IM) if pertinent